N.D. Cent. Code § 50-24.6-01

Current through 2023 Legislative Sessions

Section 50-24.6-01 - Definitions

As used in this chapter, unless the context otherwise requires:

1. "Board" means the drug use review board.

2. "Compendium" means the American hospital formulary service drug information, United States pharmacopeia-drug information, the DRUGDEX information system, American medical association drug evaluations, or nonproprietary peer-reviewed medical literature.

3. "Department" means the department of health and human services.

4. "Drug use review" means a program as described in 42 U.S.C. 1396r-8(g)(2).

5. "Drug use review criteria" means standards approved by the board for use in determining whether use of a drug is likely to be medically appropriate, to be medically necessary, and not result in adverse medical outcomes.

6. "Prior authorization" means a process requiring the prescriber or the dispenser to verify with the department or the department's contractor that proposed medical use of a particular drug for a medical assistance program recipient meets predetermined criteria for coverage by the medical assistance program.

N.D.C.C. § 50-24.6-01

Amended by S.L. 2021, ch. 352 (HB 1247),§ 464, eff. 9/1/2022.